But despite a pending marketing application, it is unclear whether the FDA will let Velo stay on the market. Read More
Tags :British American Tobacco
Presentations highlighted new opportunities to accelerate harm reduction, including those involving genomics and artificial intelligence.Read More
During the event, the company will provide further details on its transformation journey. Read More
Dialogue is key to realizing the public health benefits of harm reduction, writes BAT's Danni Tower ahead of next week's Coresta.Read More
Such action would be more effective than introducing ‘redundant policies,’ says Kingsley Wheaton.Read More
The resource aims to show how science and innovation can combine to achieve a smokeless world.Read More
Several executives assume new roles. Read More
The investor acquired 4,429,740 common shares and 8,463,435 Class A preferred shares.Read More
Its factory has been idle due to the government’s reluctance to issue the required licenses. Read More
Performance suffered from the firm’s exit from Russia, its write-down of combustibles and competition from illicit vapes. Read More
